dismiss

Clean Sweep Live Auction on Wed. February 27th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Operating Room Homepage

FDA clears next SIG Medical AdvantageRib System

Corindus announces FDA submission for neurovascular intervention indication for CorPath GRX vascular robotic system

Minimally-invasive treatment option for early stage oral cancer reduces recovery time, improves survival

Inspired Spine releases study on the clinical and radiological outcomes of oblique lateral lumbar interbody fusion

Minimally invasive surgery for brain bleeds may not be better at restoring function, says study

Leviticus Cardio & Jarvik Heart unveil groundbreaking wireless heart pump system

Southern New Hampshire Medical Center first to deploy 7D Surgical’s machine-vision image guided surgery system in New Hampshire

GS1 US releases point-of-care scanning for surgical implants implementation guidance

Medical University of South Carolina performs world’s first prostate cancer surgery using Blu Build Brachytherapy System

Zimmer Biomet receives FDA clearance for ROSA Knee System for robotically-assisted surgeries

MU orthopaedic surgeon begins FDA-approved study for novel knee-cartilage implant

Press releases may be edited for formatting or style
COLUMBIA, Mo. (February 4, 2019) ― Seth L. Sherman, MD, a sports medicine orthopaedic surgeon at University of Missouri Health Care's Missouri Orthopaedic Institute, recently became one of the first American surgeons to enroll patients in a clinical research study aimed at earning FDA approval for a new knee-cartilage implant.

Agili-C™ (CartiHeal, Israel) is a new implant designed to help patients with knee-cartilage defects regenerate their own healthy cartilage. The implant has been shown to be safe and effective in a series of clinical trials previously conducted in Europe and Israel. Sherman is one of 15 primary investigators in the United States conducting the FDA-approved study, which is the final step before earning FDA approval for the implant.

Story Continues Below Advertisement

GE Healthcare ultrasound probe solutions to help protect your investment

GE Healthcare helps reduce the downtime of ultrasounds with online access to probe and accessory purchasing, probe-failure diagnoses, fast repairs and replacements, probe care and handling tips, and reliable service options.



"We are thrilled to be on the leading edge of orthopaedic sports medicine and joint preservation," Sherman said. "In the U.S., there are limited options for off-the-shelf cartilage repair that can be performed during a single surgical procedure. Benefits of this technology include its relative low cost, ease of use, and strong basic science and clinical track record."

Cartilage damage is a common knee problem that occurs in patients of all ages. It can happen as a result of an injury, like a blow to the knee, or due to wear and tear over time. In any case, it causes knee swelling, stiffness and pain that can reduce function and decrease quality of life.

The Agili-C™ implant is a cell-free implant made of the inorganic exoskeleton of sea coral. The implant can be used in this study to treat a variety of cartilage defects and patient types, which is another reason it is attractive to orthopaedic surgeons.

"Often in studies like this one, we can enroll only a very strict subset of young, active patients with a single, isolated cartilage defect," said Sherman. "In reality, that's not the type of patient we see every day. This implant is different because it's medically indicated for a wide range of situations, including patients with multiple cartilage defects and even those with mild to moderate osteoarthritis. We can use it in patients who are in their 20s or in those who are in their 60s. This versatility allows us to find more patients who may benefit from this procedure."

Those who qualify for the study are randomly assigned either one of the traditional surgical options or the new implant. So far, Sherman has enrolled four patients in the study. He plans to enroll at least 25 before submitting his research to the FDA.

The implant is manufactured by CartiHeal, a medical device company headquartered in Kfar Saba, Isreal and Closter, New Jersey. To date, more than 400 patients in Europe and Israel -- where the device has already been approved -- have received the new implant. The Agili-CTM implant is not available for sale in the United States. It is an investigational device limited for use in the device study.

Operating Room Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED